1/12
09:00 am
masi
Masimo Announces Select Preliminary 2025 Financial Results
Medium
Report
Masimo Announces Select Preliminary 2025 Financial Results
1/7
09:00 am
masi
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
Low
Report
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
1/1
06:40 am
masi
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets [Yahoo! Finance]
Low
Report
Wells Fargo Maintains Overweight on Masimo (MASI) Following Investor Day Confidence In Long-Range Revenue Targets [Yahoo! Finance]
12/5
03:20 pm
masi
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Low
Report
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
12/5
07:21 am
masi
Masimo (NASDAQ:MASI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Masimo (NASDAQ:MASI) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
12/4
08:05 am
masi
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
Medium
Report
Masimo (NASDAQ:MASI) had its price target raised by analysts at BTIG Research from $198.00 to $200.00. They now have a "buy" rating on the stock.
12/3
04:10 pm
masi
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
Medium
Report
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth
12/1
07:03 am
masi
Masimo (NASDAQ:MASI) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
Low
Report
Masimo (NASDAQ:MASI) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.
11/24
08:06 am
masi
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Low
Report
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
11/18
09:00 am
masi
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
Low
Report
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case
11/17
08:06 am
masi
Masimo (NASDAQ:MASI) is now covered by analysts at Bank of America Corporation. They set a "neutral" rating and a $162.00 price target on the stock.
Medium
Report
Masimo (NASDAQ:MASI) is now covered by analysts at Bank of America Corporation. They set a "neutral" rating and a $162.00 price target on the stock.
11/14
08:55 pm
masi
Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages
Medium
Report
Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages
11/13
09:49 am
masi
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
Low
Report
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
11/5
10:49 am
masi
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
Low
Report
Masimo (NASDAQ:MASI) had its price target lowered by analysts at Wells Fargo & Company from $190.00 to $187.00. They now have an "overweight" rating on the stock.
11/5
08:08 am
masi
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
Low
Report
Masimo (NASDAQ:MASI) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $198.00 price target on the stock.
11/4
04:05 pm
masi
Masimo Reports Third Quarter 2025 Results
Medium
Report
Masimo Reports Third Quarter 2025 Results
10/28
06:19 am
masi
Masimo (NASDAQ:MASI) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Masimo (NASDAQ:MASI) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
10/23
01:00 pm
masi
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights
Low
Report
Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights
10/21
09:00 am
masi
Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4
Low
Report
Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4